[go: up one dir, main page]

NO20072642L - Use of androgens to reduce the likelihood of acquiring or to treat skin aging - Google Patents

Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Info

Publication number
NO20072642L
NO20072642L NO20072642A NO20072642A NO20072642L NO 20072642 L NO20072642 L NO 20072642L NO 20072642 A NO20072642 A NO 20072642A NO 20072642 A NO20072642 A NO 20072642A NO 20072642 L NO20072642 L NO 20072642L
Authority
NO
Norway
Prior art keywords
likelihood
acquiring
loss
androgens
reduce
Prior art date
Application number
NO20072642A
Other languages
English (en)
Norwegian (no)
Inventor
Fernand Labrie
Mohamed El-Alfy
Lamia Azzi
Original Assignee
Endorech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorech Inc filed Critical Endorech Inc
Publication of NO20072642L publication Critical patent/NO20072642L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
NO20072642A 2004-11-01 2007-05-23 Use of androgens to reduce the likelihood of acquiring or to treat skin aging NO20072642L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62411204P 2004-11-01 2004-11-01
PCT/CA2005/001652 WO2006047859A1 (fr) 2004-11-01 2005-10-31 Utilisation d'androgenes pour retarder le vieillissement de la peau ou traiter celui-ci

Publications (1)

Publication Number Publication Date
NO20072642L true NO20072642L (no) 2007-07-30

Family

ID=36318842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072642A NO20072642L (no) 2004-11-01 2007-05-23 Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Country Status (20)

Country Link
US (1) US20060178352A1 (fr)
EP (1) EP1807062A4 (fr)
JP (1) JP2008517952A (fr)
KR (1) KR20070073964A (fr)
CN (1) CN101094676A (fr)
AP (1) AP2007003982A0 (fr)
AU (1) AU2005301035A1 (fr)
BR (1) BRPI0517950A (fr)
CA (1) CA2585666A1 (fr)
EA (1) EA200700983A1 (fr)
GE (1) GEP20094833B (fr)
HR (1) HRP20070183A2 (fr)
IL (1) IL182844A0 (fr)
MA (1) MA29220B1 (fr)
MX (1) MX2007005098A (fr)
NO (1) NO20072642L (fr)
RS (1) RS20070185A (fr)
TN (1) TNSN07163A1 (fr)
WO (1) WO2006047859A1 (fr)
ZA (1) ZA200703531B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201404796QA (en) 2004-10-20 2014-10-30 Endorech Inc Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
US8269380B2 (en) 2006-06-01 2012-09-18 Panasonic Corporation Brushless motor for washing machine having stress reduction on sensor casing and washing machine having the brushless motor mounted therein
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
WO2015055179A1 (fr) * 2013-10-15 2015-04-23 Chelac Holding Gmbh Esters d'acide stéroïde-carboxylique, compositions contenant des esters d'acide stéroïde-carboxylique et leur utilisation dans une application localement topique à des fins cosmétiques ou dermatologiques
JP6444956B2 (ja) * 2015-09-30 2018-12-26 富士フイルム株式会社 経皮吸収用組成物
CN114728013A (zh) * 2019-09-23 2022-07-08 斯坦福大学托管董事会 延长妊娠以及月经或妊娠的并发症的治疗方法
US12426782B2 (en) 2020-11-06 2025-09-30 The Board Of Trustees Of The Leland Stanford Junior University Systems and temporal alignment methods for evaluation of gestational age and time to delivery

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL190146A (fr) * 1953-08-26
CN1100541C (zh) * 1993-01-19 2003-02-05 恩多研究公司 脱氢表雄酮的治疗用途和传送系统
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
TR200102867T2 (fr) * 1998-06-11 2002-06-21 Endorecherchel@Inc
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
FR2803750B1 (fr) * 2000-01-17 2004-04-02 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US20030027804A1 (en) * 2001-06-27 2003-02-06 Van Der Hoop Roland Gerritsen Therapeutic combinations for the treatment of hormone deficiencies
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
IL157535A0 (en) * 2003-08-21 2004-03-28 Topimed Ltd Preparations for the prevention of skin atrophy

Also Published As

Publication number Publication date
GEP20094833B (en) 2009-11-25
CA2585666A1 (fr) 2006-05-11
KR20070073964A (ko) 2007-07-10
HRP20070183A2 (en) 2007-08-31
TNSN07163A1 (en) 2008-11-21
ZA200703531B (en) 2008-07-30
IL182844A0 (en) 2007-09-20
BRPI0517950A (pt) 2008-10-21
EP1807062A4 (fr) 2009-06-03
CN101094676A (zh) 2007-12-26
AU2005301035A1 (en) 2006-05-11
MX2007005098A (es) 2008-01-16
AP2007003982A0 (en) 2007-06-30
EP1807062A1 (fr) 2007-07-18
RS20070185A (sr) 2008-09-29
JP2008517952A (ja) 2008-05-29
MA29220B1 (fr) 2008-02-01
EA200700983A1 (ru) 2008-04-28
US20060178352A1 (en) 2006-08-10
WO2006047859A1 (fr) 2006-05-11

Similar Documents

Publication Publication Date Title
NO20072642L (no) Use of androgens to reduce the likelihood of acquiring or to treat skin aging
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
DE502005001762D1 (de) Verwendung von N-Hydroxyalkyl-O-benzylchitosanen zur Haarbehandlung
TW200509956A (en) Compositions and methods for treatment of rosacea
DE60135755D1 (de) Verbindungen und methoden zur behandlung von hautverletzungen
WO2005079143A3 (fr) Formulations topiques pour le traitement d'etats dermatologiques
WO2007099398A3 (fr) procédés et compositions pour le traitement de la peau
WO2008070859A3 (fr) Traitement d'affections cutanées par dickkopf1 (dkk1)
DE60103894D1 (de) Sprühfähige wundversorgungszusammensetzung
EA201290698A1 (ru) Композиция, содержащая экстракт венериной мухоловки для косметической обработки
MX2011010781A (es) Una crema medicinal hecha con sulfadiazina de plata y quitosano y un proceso para hacerla.
AU2010300611A8 (en) Hematopoietic stem cells for use in the treatment of a kidney injury
EA202191211A1 (ru) Композиции и способы для обработки транзиторных биопленок
WO2006073786A3 (fr) Compositions opthalmiques comprenant un steroide et une cyclosporine pour le traitement de l'oeil sec
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
NO20060498L (no) Metode for a promotere benvekst
Lou et al. Analysis of the effectiveness of basic fibroblast growth factor treatment on traumatic perforation of the tympanic membrane at different time points
ATE553760T1 (de) Verwendung von alverin zur behandlung von hauterkrankungen
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
BRPI0512503A (pt) composição que compreende ácido lático e lactoferrina
AU2020327022A8 (en) Method of treating cancer
US10874883B2 (en) Product for treating the skin and mucous membranes, and relative method of preparation
MXPA04011018A (es) Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.
UA88175C2 (ru) Способ косметической обработки стареющей кожи при помощи местного применения композиции, которая содержит циклогексанмоно-, -ди- или -триолы или циклогексилметан- или -этан-, или -пропанолы
ATE483465T1 (de) Verwendung eines gleditsia-extrakts für kosmetik und dermatologie

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application